Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Tran K, Coyle K, Jabr MF, et al. Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Mar.
Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness [Internet].
Show detailsTable 127. Data of 6MWD, Mean Change From Baseline (Total)
Table 128. Data of 6MWD, Mean Change From Baseline (Naive)
Table 129. Data of 6MWD, Mean Change From Baseline (Add-on)
Table 130. Data of Clinical Worsening (Total)
Table 131. Data of Clinical Worsening (Naive)
Table 132. Data of Clinical Worsening (Add-on)
Table 133. Data of Hospitalization (Total)
Table 134. Data of Functional Class, Improved (Total)
Table 135. Data of Functional Class, Improved (Naive)
Table 136. Data of Functional Class, Improved (Add-on)
Table 137. Data of Functional Class, Unchanged (Total)
Table 138. Data of Functional Class, Unchanged (Naive)
Table 139. Data of Functional Class, Unchanged (Add-on)
Table 140. Data of Functional Class, Worsened (Total)
Table 141. Data of Functional Class, Worsened (Naive)
Table 142. Data of Functional Class, Worsened (Add-on)
Table 143. Data of Borg Dyspnea Index, Mean Change From Baseline (Total)
Table 144. Data of Borg Dyspnea Index, Mean Change From Baseline (Naive)
Table 145. Data of Borg Dyspnea Index, Mean Change From Baseline (Add-on)
Table 146. Data of Pulmonary Vascular Resistance, mean change from baseline (Total)
Table 147. Data of Pulmonary Vascular Resistance, Mean Change From Baseline (Naive)
Table 148. Data of Pulmonary Vascular Resistance, Mean Change From Baseline (Add-on)
Table 149. Data of Pulmonary Artery Pressure, Mean Change From Baseline (Total)
Table 150. Data of Pulmonary Artery Pressure, Mean Change From Baseline (Naive)
Table 151. Data of Pulmonary Artery Pressure, Mean Change From Baseline (Add-on)
Table 152. Data of Cardiac Index, Mean Change From Baseline (Total)
Table 153. Data of Cardiac Index, Mean Change From Baseline (Naive)
Table 154. Data of Cardiac Index, Mean Change From Baseline (Add-on)
Table 155. Data of Mortality (Total)
Table 156. Data of Serious Adverse Events (Other Than Death) (Total)
Table 157. Data of Drug Discontinuation Due to Adverse Events (Other Than Death) (Total)
Table 158. Data of Total Withdrawal (Including Death) (Total)
Table 159. Data of Liver Toxicity (Total)
Table 160. Data of Edema (Total)
- DETAILED DATA OF MONOTHERAPY AND ADD-ON THERAPY TRIALS - Drugs for Pulmonary Art...DETAILED DATA OF MONOTHERAPY AND ADD-ON THERAPY TRIALS - Drugs for Pulmonary Arterial Hypertension: Comparative Efficacy, Safety, and Cost-Effectiveness
- PREDICTED: Momordica charantia uncharacterized membrane protein YuiD-like (LOC11...PREDICTED: Momordica charantia uncharacterized membrane protein YuiD-like (LOC111011023), mRNAgi|1229774560|ref|XM_022284629.1|Nucleotide
- Homo sapiensHomo sapiensAlternative poly(A) in Alzheimer's disaseBioProject
- Related Structures (List) for Protein (Select 41053854) (81)Structure
- BioSample links for Nucleotide (Select 656046) (1)BioSample
Your browsing activity is empty.
Activity recording is turned off.
See more...